Axon Enterprise (NASDAQ:AXON) Issues Quarterly Earnings Results

Axon Enterprise (NASDAQ:AXON) released its quarterly earnings data on Monday. The biotechnology company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.20, Briefing.com reports. The business had revenue of $460.74 million during the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 14.11% and a net margin of 11.14%. During the same period last year, the company posted $0.51 EPS. The company’s revenue was up 34.3% compared to the same quarter last year. Axon Enterprise updated its FY 2024 guidance to EPS.

Axon Enterprise Trading Up 2.9 %

NASDAQ AXON opened at $327.64 on Tuesday. Axon Enterprise has a 52 week low of $175.37 and a 52 week high of $329.87. The stock’s 50 day moving average price is $309.95 and its two-hundred day moving average price is $266.41. The stock has a market capitalization of $24.72 billion, a price-to-earnings ratio of 142.45 and a beta of 0.91. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.66 and a current ratio of 3.00.

Wall Street Analyst Weigh In

Several research firms have issued reports on AXON. TheStreet downgraded Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. Barclays raised their target price on Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research report on Wednesday, April 24th. Robert W. Baird boosted their price target on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Finally, The Goldman Sachs Group boosted their target price on Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $323.09.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.